Moore RG
No ORCID on file
· 11 papers in corpus
· active 2007-2024
Study types
- article 1
- case-report 1
- other 1
Condition tags
- endometriosis 3
Top journals
Frequent coauthors
- Miller MC 4
- Robert C. Bast 4
- Lambert-Messerlian G 3
- Skates SJ 3
- DiSilvestro P 3
- Lu KH 3
- Richard G. Moore 3
- Bast RC Jr 2
- Kishor K 2
- Granai CO 2
2024
Ovarian cancer is the leading cause of death among gynecologic malignancies. Despite recent advancements in targeted therapies such as PARP inhibitors, recurrence is common and frequently resistant to existing therapies. A powerful diagnost…
2022
Vitamin-D receptor (VDR) mRNA is overexpressed in neuroblastoma and carcinomas of lung, pancreas, and ovaries and predicts poor prognoses. VDR antagonists may be able to inhibit tumors that overexpress VDR. However, the current antagonists …
case-report
2022
BACKGROUND/OBJECTIVE: Epithelial cell ovarian carcinomas rarely secrete steroid hormones, while sex cord and stromal cell ovarian carcinomas often do so. The objective of this report is to describe a patient with endometrioid ovarian carcin…
2015
ObjectiveTo evaluate the use of as an aid in the identification of women who can safely undergo conservative, non-surgical management.MethodsAll patients referred to the Program in Women's Oncology for surgery with a pelvic mass are evaluat…
article
2014
ObjectivesTo determine predictive factors for the presence of malignant transformation in ovarian endometriotic cysts.Study designThis was an IRB approved, case control study analyzing patient data from 2004 to 2013. Pathology database reco…
other
2012
OBJECTIVE: The human epididymis protein 4 (HE4) is a novel biomarker for ovarian cancer. This study measured the HE4 and CA125 levels in women with benign gynecological disorders. STUDY DESIGN: Sera were obtained from women prior to surger…
2012
ObjectiveThe purpose of this study was to establish normal ranges for human epididymis protein 4 (HE4) serum levels in healthy women.Study designHE4 levels were measured in healthy women and analyzed by age, menopausal status, and pregnancy…
2011
ObjectiveIt is often difficult to distinguish a benign pelvic mass from a malignancy and tools to help referring physician are needed. The purpose of this study was to validate the Risk of Ovarian Malignancy Algorithm in women presenting wi…
2010
Each year in the United States over 15,000 women die of epithelial ovarian cancer (EOC) and 22,000 are diagnosed with the disease. The incidence of ovarian cancer has remained stable over the past decade however, survival rates have improve…
2009
IntroductionPatients diagnosed with epithelial ovarian cancer (EOC) have improved outcomes when cared for at centers experienced in the management of EOC. The objective of this trial was to validate a predictive model to assess the risk for…
2007
ObjectivesEarly detection of ovarian cancer should improve overall survival. Multiple serum markers have been evaluated as possible tests to detect early stage disease, but few urine markers have been studied. Mesothelin has been detected i…